Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Brett Fleisher, Jovin Lezeau, Carolin Werkman, Brehanna Jacobs & Sihem Ait-Oudhia. (2021) In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach. Breast Cancer: Targets and Therapy 13, pages 87-105.
Read now
Read now
Brett Fleisher, Hardik Mody, Carolin Werkman & Sihem Ait-Oudhia. (2019) Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy–apoptosis crosstalk pathway. Breast Cancer: Targets and Therapy 11, pages 231-241.
Read now
Read now
Frantisek Straka, David Schornik, Jaroslav Masin, Elena Filova, Tomas Mirejovsky, Zuzana Burdikova, Zdenek Svindrych, Hynek Chlup, Lukas Horny, Matej Daniel, Jiri Machac, Jelena Skibová, Jan Pirk & Lucie Bacakova. (2018) A human pericardium biopolymeric scaffold for autologous heart valve tissue engineering: cellular and extracellular matrix structure and biomechanical properties in comparison with a normal aortic heart valve. Journal of Biomaterials Science, Polymer Edition 29:6, pages 599-634.
Read now
Read now
Articles from other publishers (10)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Rohit Patil, Sanjay Singh, Dinesh Kumar & Ashish Kumar Agrawal. (2023) Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology. Cancers 15:9, pages 2661.
Crossref
Crossref
Suma L. Sivan & Vinod Chandra S. Sukumara Pillai. (2021) Smell Detection Agent Optimisation Framework and Systems Biology Approach to Detect Dys-Regulated Subnetwork in Cancer Data. Biomolecules 12:1, pages 37.
Crossref
Crossref
Margarite D. Matossian, Van T. Hoang, Hope E. Burks, Jacqueline La, Steven Elliott, Courtney Brock, Douglas B. Rusch, Aaron Buechlein, Kenneth P. Nephew, Akshita Bhatt, Jane E. Cavanaugh, Patrick T. Flaherty, Bridgette M. Collins-Burow & Matthew E. Burow. (2021) Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer. Oncoscience 8, pages 61-71.
Crossref
Crossref
Vani Parmar, Nita S Nair, Purvi Thakkar & Garvit Chitkara. (2019) Molecular Biology in the Breast Clinics—Current status and future perspectives. Indian Journal of Surgical Oncology 12:S1, pages 7-20.
Crossref
Crossref
Yuqian Huang, Zhen Yang, Feng Li, Hong Zhao, Chun Li, Nam Yu, Dale J. Hamilton & Zheng Li. (2021)
64
Cu/
177
Lu-DOTA-diZD, a Small-Molecule-Based Theranostic Pair for Triple-Negative Breast Cancer
. Journal of Medicinal Chemistry 64:5, pages 2705-2713.
Crossref
Crossref
Elif Damla Arisan, Ozge Rencuzogullari, Clara Cieza-Borrella, Francesc Miralles Arenas, Miriam Dwek, Sigrun Lange & Pinar Uysal-Onganer. (2021) MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells. International Journal of Molecular Sciences 22:4, pages 1557.
Crossref
Crossref
Sonar Soni Panigoro, Dian Kurnia, Ahmad Kurnia, Samuel Johny Haryono & Zafiral Azdi Albar. (2020) ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer. International Journal of Surgical Oncology 2020, pages 1-7.
Crossref
Crossref
Caroline K. Søgaard, Anala Nepal, Voin Petrovic, Animesh Sharma, Nina-Beate Liabakk, Tonje S. Steigedal & Marit Otterlei. (2019) Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy. Oncotarget 10:68, pages 7185-7197.
Crossref
Crossref
Yu-ting Zhou, Juan-juan Qiu, Yao Wang, Peng-cheng Liu, Qing Lv & Zheng-gui Du. (2019) Sperm Protein Antigen 17 Expression Correlates With Lymph Node Metastasis and Worse Overall Survival in Patients With Breast Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Rosa Mistica C. Ignacio, Carla R. Gibbs, Soohyun Kim, Eun-Sook Lee, Samuel E. Adunyah & Deok-Soo Son. (2019) Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer. Oncotarget 10:4, pages 511-526.
Crossref
Crossref